Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (NCT06072612)
Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer.
🩺 Plain-English Summary (8th-Grade Level)
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Who can join: Review the eligibility criteria below.
Location: Mayo Clinic-Comprehensive Cancer Center-Breast Clinic — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (79 Sites)
Showing the first 25 of 79 sites.
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic — Phoenix, Arizona
- University of Arizona-Cancer Center — Tucson, Arizona
- Los Angeles cancer Network_Anaheim — Anaheim, California
- Comprehensive Blood and Cancer Center — Bakersfield, California
- Cedars-Sinai Cancer Beverly Hills — Beverly Hills, California
- Los Angeles Cancer Network_Corona — Corona, California
- Los Angeles cancer Network_Fountain Vallley — Fountain Valley, California
- Los Angeles Cancer Network_Glendale — Glendale, California
- Hoag Hospital Center — Irvine, California
- Hoag Hospital Irvine — Irvine, California
- Los Angeles Cancer Network — Los Angeles, California
- Cedars-Sinai Cancer at Cedars-Sinai Medical Facility — Los Angeles, California
- Los Angeles Cancer Network_Century City — Los Angeles, California
- UCLA-Hematology/Oncology Medical Plaza — Los Angeles, California
- UCLA-Hematology/Oncology_LA 2 — Los Angeles, California
- UCLA-Hematology/Oncology_LA — Los Angeles, California
- Los Angeles Cancer Network_Pasadena — Pasadena, California
- Los Angeles cancer Network_Riverside — Riverside, California
- UC San Diego — San Diego, California
- St. John's Cancer Center — Santa Monica, California
- UCLA-Department of Medicine Hematology/Oncology-Parkside — Santa Monica, California
- UCLA-Hetamtology/Oncology_S Monica — Santa Monica, California
- Torrance Memorial Cancer Center — Torrance, California
- Los Angeles Cancer Network_Valley Pres — Van Nuys, California
- Cedars-Sinai Breast Health Services Building — West Hollywood, California
📞 Contact the Study Coordinator
Phone: (919) 413-5961
Email: patientreferral@prevailinfoworks.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.